About Motif neurotech
Motif neurotech is a company based in Houston (United States) founded in 2022 by Jacob Robinson. Motif neurotech has raised $18.75 million across 1 funding round from investors including Arboretum Ventures, KdT Ventures and Satori Capital. Motif neurotech offers products and services including DOT. Motif neurotech operates in a competitive market with competitors including Freespira, Sooma Oy, Neuronetics, Spark Biomedical and Inner Cosmos, among others.
- Headquarter Houston, United States
- Founders Jacob Robinson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.75 M (USD)
in 1 rounds
-
Latest Funding Round
$18.75 M (USD), Series A
Jan 24, 2024
-
Investors
Arboretum Ventures
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Motif neurotech
Motif neurotech offers a comprehensive portfolio of products and services, including DOT.
Treats depression by activating brain networks in outpatient settings.
People of Motif neurotech
Unlock access to complete
Leadership Team
3 people
Product Management Team
2 people
Operations Team
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of Motif neurotech
Motif neurotech has successfully raised a total of $18.75M through 1 strategic funding round. The most recent funding activity was a Series A round of $18.75 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Motif neurotech
Motif neurotech has secured backing from 11 investors, including venture fund and angel investors. Prominent investors backing the company include Arboretum Ventures, KdT Ventures and Satori Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in frontier science ventures.
|
Locked | Locked | Locked | |
|
Investment firm specializing in private equity, alternatives, and thematic strategies with a focus on long-term value.
|
Locked | Locked | Locked |
Investor details for Motif neurotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Motif neurotech
Investment portfolio details for Motif neurotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Motif neurotech
Detailed financials for Motif neurotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Motif Neurotech Comparisons
Peer comparison for Motif neurotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Motif neurotech
Motif neurotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Freespira, Sooma Oy, Neuronetics, Spark Biomedical and Inner Cosmos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Panic disorders are treated via breathing device and mobile app.
|
|
| Locked | Locked | Locked |
Non-invasive neuromodulation therapies
|
|
| Locked | Locked | Locked |
Non-invasive magnetic therapies for psychiatric and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for opioid withdrawal symptoms are developed.
|
|
| Locked | Locked | Locked |
AI-based implantable device for mood and addiction treatment is provided.
|
Detailed competitors of Motif neurotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Motif Neurotech
Complete news archive for Motif neurotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Motif neurotech
Motif neurotech was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Motif neurotech is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Jacob Robinson is the current CEO of Motif neurotech. They have also founded this company.
Motif neurotech is a funded company, having raised a total of $18.75M across 1 funding round to date.
Motif Neurotech was founded in 2022 in Houston, United States. Operations focus on the bioelectronics sector, where minimally invasive devices are created to address mental health conditions. A miniature brain pacemaker is developed to stimulate neural circuits, aiming to restore healthy brain activity. This approach targets disorders such as treatment-resistant depression, with development centered in the United States.
Motif neurotech's top competitors include NeuroSigma, Spark Biomedical and Neuronetics.
Motif neurotech offers DOT.
Motif neurotech has 11 investors. Key investors include Arboretum Ventures, KdT Ventures, Satori Capital, Dolby Family Ventures, and re.Mind Capital.